Pfizer, Allergan terminate $160bn merger deal

Pfizer has terminated its agreement to takeover Irish Botox maker Allergan in a deal worth $160bn, after the US Department of Treasury announced its decision to bring an end to tax inversion agreements.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news